Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Aprepitant is an antiemetic compound and belongs to a class of drugs called substance P antagonists (SPA). It mediates its effects by blocking the neurokinin 1 (NK 1) receptor.
This report elaborates on the current development of the Aprepitant industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
Neuraxpharm
RA Chem Pharma Limited
Tofigh Daru
Farmhispania
Royesh Daru Pars Co
Zhongshan Follow Biotech
Cayman
Mehta
Wuhai Yuancheng Technology Co,Ltd
Hetero
Beijing Langfang Gaobo Jingbang Pharmaceutical
Jubilant Pharma
Bondbay Pharma
Zhongshan Enantiotech Corporation
Nanjing Gold Pharmaceutical Technology Co,Ltd
Wujiang Xiehe Pharmaceutical Co,Ltd
Chengdu Henghui Pharmaceutical
By Type:
Purity;98%-99%
Purity:>99%
By Application:
Prevent Postoperative Nausea and Vomiting
Preventing Cancer from Vomiting
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Aprepitant Market Overview 2018-2029
-
1.1 China Aprepitant Industry Development Overview
-
1.2 China Aprepitant Industry Development History
-
1.3 China Aprepitant Industry Market Size (2018-2029)
-
1.4 China Aprepitant Market Analysis by Type from Production Side
-
1.4.1 China Aprepitant Production Volume, Production Value and Growth Rate of Purity;98%-99% (2018-2029)
-
1.4.2 China Aprepitant Production Volume, Production Value and Growth Rate of Purity:>99% (2018-2029)
-
1.5 China Aprepitant Market Analysis by Application from Consumption End
-
1.5.1 China Aprepitant Sales Volume, Sales Value and Growth Rate of Prevent Postoperative Nausea and Vomiting (2018-2029)
-
1.5.2 China Aprepitant Sales Volume, Sales Value and Growth Rate of Preventing Cancer from Vomiting (2018-2029)
-
1.6 China Aprepitant Market Analysis by Region
-
1.6.1 North China Aprepitant Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Aprepitant Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Aprepitant Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Aprepitant Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Aprepitant Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Aprepitant Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Aprepitant Market Size and Growth Rate from 2018-2029
Chapter 2 China Aprepitant Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Aprepitant Market Status and Competition at home and abroad in 2023
-
2.2.2 China Aprepitant Market Status and Competition Analysis in 2023
-
2.2.3 China Aprepitant Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Aprepitant Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Aprepitant Industry Development
Chapter 3 AprepitantIndustry Chain Analysis
-
3.1 Aprepitant Industry Chain
-
3.2 Aprepitant Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Aprepitant Market
-
3.3 Aprepitant Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Aprepitant Market
Chapter 4 China Aprepitant Market, by Type
-
4.1 China Aprepitant Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Aprepitant Total Production Volume and Growth Rate from Production Side
-
4.5 China Aprepitant Production Volume and Growth Rate, by Type
-
4.5.1 China Aprepitant Production Volume and Growth Rate of Purity;98%-99%
-
4.5.2 China Aprepitant Production Volume and Growth Rate of Purity:>99%
Chapter 5 China Aprepitant Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Aprepitant Total Market Size and Growth Rate from Consumption End
-
5.5 China Aprepitant Market Size and Growth Rate, by Application
-
5.5.1 China Aprepitant Market Size and Growth Rate of Prevent Postoperative Nausea and Vomiting
-
5.5.2 China Aprepitant Market Size and Growth Rate of Preventing Cancer from Vomiting
Chapter 6 China Aprepitant Market, by Region
-
6.1 China Aprepitant Production Volume and Production Value, by Region
-
6.2 China Aprepitant Sales Volume and Sales Value, by Region
Chapter 7 North China Aprepitant Market Analysis
-
7.1 North China Aprepitant Market, by Type
-
7.2 North China Aprepitant Market, by Application
Chapter 8 Central China Aprepitant Market Analysis
-
8.1 Central China Aprepitant Market, by Type
-
8.2 Central China Aprepitant Market, by Application
Chapter 9 South China Aprepitant Market Analysis
-
9.1 South China Aprepitant Market, by Type
-
9.2 South China Aprepitant Market, by Application
Chapter 10 East China Aprepitant Market Analysis
-
10.1 East China Aprepitant Market, by Type
-
10.2 East China Aprepitant Market, by Application
Chapter 11 Northeast China Aprepitant Market Analysis
-
11.1 Northeast China Aprepitant Market, by Type
-
11.2 Northeast China Aprepitant Market, by Application
Chapter 12 Southwest China Aprepitant Market Analysis
-
12.1 Southwest China Aprepitant Market, by Type
-
12.2 Southwest China Aprepitant Market, by Application
Chapter 13 Northwest China Aprepitant Market Analysis
-
13.1 Northwest China Aprepitant Market, by Type
-
13.2 Northwest China Aprepitant Market, by Application
Chapter 14 Company Profiles
-
14.1 Neuraxpharm
-
14.1.1 Neuraxpharm Company Profile
-
14.1.2 Neuraxpharm Aprepitant Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 RA Chem Pharma Limited
-
14.2.1 RA Chem Pharma Limited Company Profile
-
14.2.2 RA Chem Pharma Limited Aprepitant Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 Tofigh Daru
-
14.3.1 Tofigh Daru Company Profile
-
14.3.2 Tofigh Daru Aprepitant Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 Farmhispania
-
14.4.1 Farmhispania Company Profile
-
14.4.2 Farmhispania Aprepitant Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 Royesh Daru Pars Co
-
14.5.1 Royesh Daru Pars Co Company Profile
-
14.5.2 Royesh Daru Pars Co Aprepitant Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 Zhongshan Follow Biotech
-
14.6.1 Zhongshan Follow Biotech Company Profile
-
14.6.2 Zhongshan Follow Biotech Aprepitant Market Performance
-
14.6.3 Product&Service Introduction
-
14.7 Cayman
-
14.7.1 Cayman Company Profile
-
14.7.2 Cayman Aprepitant Market Performance
-
14.7.3 Product&Service Introduction
-
14.8 Mehta
-
14.8.1 Mehta Company Profile
-
14.8.2 Mehta Aprepitant Market Performance
-
14.8.3 Product&Service Introduction
-
14.9 Wuhai Yuancheng Technology Co,Ltd
-
14.9.1 Wuhai Yuancheng Technology Co,Ltd Company Profile
-
14.9.2 Wuhai Yuancheng Technology Co,Ltd Aprepitant Market Performance
-
14.9.3 Product&Service Introduction
-
14.10 Hetero
-
14.10.1 Hetero Company Profile
-
14.10.2 Hetero Aprepitant Market Performance
-
14.10.3 Product&Service Introduction
-
14.11 Beijing Langfang Gaobo Jingbang Pharmaceutical
-
14.11.1 Beijing Langfang Gaobo Jingbang Pharmaceutical Company Profile
-
14.11.2 Beijing Langfang Gaobo Jingbang Pharmaceutical Aprepitant Market Performance
-
14.11.3 Product&Service Introduction
-
14.12 Jubilant Pharma
-
14.12.1 Jubilant Pharma Company Profile
-
14.12.2 Jubilant Pharma Aprepitant Market Performance
-
14.12.3 Product&Service Introduction
-
14.13 Bondbay Pharma
-
14.13.1 Bondbay Pharma Company Profile
-
14.13.2 Bondbay Pharma Aprepitant Market Performance
-
14.13.3 Product&Service Introduction
-
14.14 Zhongshan Enantiotech Corporation
-
14.14.1 Zhongshan Enantiotech Corporation Company Profile
-
14.14.2 Zhongshan Enantiotech Corporation Aprepitant Market Performance
-
14.14.3 Product&Service Introduction
-
14.15 Nanjing Gold Pharmaceutical Technology Co,Ltd
-
14.15.1 Nanjing Gold Pharmaceutical Technology Co,Ltd Company Profile
-
14.15.2 Nanjing Gold Pharmaceutical Technology Co,Ltd Aprepitant Market Performance
-
14.15.3 Product&Service Introduction
-
14.16 Wujiang Xiehe Pharmaceutical Co,Ltd
-
14.16.1 Wujiang Xiehe Pharmaceutical Co,Ltd Company Profile
-
14.16.2 Wujiang Xiehe Pharmaceutical Co,Ltd Aprepitant Market Performance
-
14.16.3 Product&Service Introduction
-
14.17 Chengdu Henghui Pharmaceutical
-
14.17.1 Chengdu Henghui Pharmaceutical Company Profile
-
14.17.2 Chengdu Henghui Pharmaceutical Aprepitant Market Performance
-
14.17.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Aprepitant Industry Research Conclusions
-
15.2 Aprepitant Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Aprepitant Industry Market Size (2018-2029)
-
Figure China Aprepitant Production Volume, Production Value and Growth Rate of Purity;98%-99% (2018-2029)
-
Figure China Aprepitant Production Volume, Production Value and Growth Rate of Purity:>99% (2018-2029)
-
Figure China Aprepitant Sales Volume, Sales Value and Growth Rate of Prevent Postoperative Nausea and Vomiting (2018-2029)
-
Figure China Aprepitant Sales Volume, Sales Value and Growth Rate of Preventing Cancer from Vomiting (2018-2029)
-
Figure North China Aprepitant Market Size and Growth Rate from 2018-2029
-
Figure Central China Aprepitant Market Size and Growth Rate from 2018-2029
-
Figure South China Aprepitant Market Size and Growth Rate from 2018-2029
-
Figure East China Aprepitant Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Aprepitant Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Aprepitant Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Aprepitant Market Size and Growth Rate from 2018-2029
-
Figure Aprepitant Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Aprepitant Market Share by Type in 2018
-
Figure China Aprepitant Market Share by Type in 2023
-
Figure China Aprepitant Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Aprepitant Production Volume and Growth Rate of Purity;98%-99% (2018-2023)
-
Figure China Aprepitant Production Volume and Growth Rate of Purity:>99% (2018-2023)
-
Figure China Aprepitant Market Share by Application in 2018
-
Figure China Aprepitant Market Share by Application in 2023
-
Figure China Aprepitant Total Market Size and Growth Rate from Consumption End
-
Figure China Aprepitant Market Size and Growth Rate of Prevent Postoperative Nausea and Vomiting (2018-2023)
-
Figure China Aprepitant Market Size and Growth Rate of Preventing Cancer from Vomiting (2018-2023)
-
Table China Aprepitant Production Volume by Region (2018-2023)
-
Table China Aprepitant Production Volume Share by Region (2018-2023)
-
Figure China Aprepitant Production Volume Share by Region (2018-2023)
-
Table China Aprepitant Production Value by Region (2018-2023)
-
Table China Aprepitant Production Value Share by Region (2018-2023)
-
Figure China Aprepitant Production Value Share by Region (2018-2023)
-
Table China Aprepitant Sales Volume by Region (2018-2023)
-
Table China Aprepitant Sales Volume Share by Region (2018-2023)
-
Figure China Aprepitant Sales Volume Share by Region (2018-2023)
-
Table China Aprepitant Sales Value by Region (2018-2023)
-
Table China Aprepitant Sales Value Share by Region (2018-2023)
-
Figure China Aprepitant Sales Value Share by Region (2018-2023)
-
Table North China Aprepitant Production Volume by Type (2018-2023)
-
Table North China Aprepitant Production Volume Share by Type (2018-2023)
-
Figure North China Aprepitant Production Volume Share by Type (2018-2023)
-
Table North China Aprepitant Sales Volume by Application (2018-2023)
-
Table North China Aprepitant Sales Volume Share by Application (2018-2023)
-
Figure North China Aprepitant Sales Volume Share by Application (2018-2023)
-
Table Central China Aprepitant Production Volume by Type (2018-2023)
-
Table Central China Aprepitant Production Volume Share by Type (2018-2023)
-
Figure Central China Aprepitant Production Volume Share by Type (2018-2023)
-
Table Central China Aprepitant Sales Volume by Application (2018-2023)
-
Table Central China Aprepitant Sales Volume Share by Application (2018-2023)
-
Figure Central China Aprepitant Sales Volume Share by Application (2018-2023)
-
Table South China Aprepitant Production Volume by Type (2018-2023)
-
Table South China Aprepitant Production Volume Share by Type (2018-2023)
-
Figure South China Aprepitant Production Volume Share by Type (2018-2023)
-
Table South China Aprepitant Sales Volume by Application (2018-2023)
-
Table South China Aprepitant Sales Volume Share by Application (2018-2023)
-
Figure South China Aprepitant Sales Volume Share by Application (2018-2023)
-
Table East China Aprepitant Production Volume by Type (2018-2023)
-
Table East China Aprepitant Production Volume Share by Type (2018-2023)
-
Figure East China Aprepitant Production Volume Share by Type (2018-2023)
-
Table East China Aprepitant Sales Volume by Application (2018-2023)
-
Table East China Aprepitant Sales Volume Share by Application (2018-2023)
-
Figure East China Aprepitant Sales Volume Share by Application (2018-2023)
-
Table Northeast China Aprepitant Production Volume by Type (2018-2023)
-
Table Northeast China Aprepitant Production Volume Share by Type (2018-2023)
-
Figure Northeast China Aprepitant Production Volume Share by Type (2018-2023)
-
Table Northeast China Aprepitant Sales Volume by Application (2018-2023)
-
Table Northeast China Aprepitant Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Aprepitant Sales Volume Share by Application (2018-2023)
-
Table Southwest China Aprepitant Production Volume by Type (2018-2023)
-
Table Southwest China Aprepitant Production Volume Share by Type (2018-2023)
-
Figure Southwest China Aprepitant Production Volume Share by Type (2018-2023)
-
Table Southwest China Aprepitant Sales Volume by Application (2018-2023)
-
Table Southwest China Aprepitant Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Aprepitant Sales Volume Share by Application (2018-2023)
-
Table Northwest China Aprepitant Production Volume by Type (2018-2023)
-
Table Northwest China Aprepitant Production Volume Share by Type (2018-2023)
-
Figure Northwest China Aprepitant Production Volume Share by Type (2018-2023)
-
Table Northwest China Aprepitant Sales Volume by Application (2018-2023)
-
Table Northwest China Aprepitant Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Aprepitant Sales Volume Share by Application (2018-2023)
-
Table Neuraxpharm Company Profile
-
Table Neuraxpharm Aprepitant Revenue, Price and Gross (2018-2023)
-
Table RA Chem Pharma Limited Company Profile
-
Table RA Chem Pharma Limited Aprepitant Revenue, Price and Gross (2018-2023)
-
Table Tofigh Daru Company Profile
-
Table Tofigh Daru Aprepitant Revenue, Price and Gross (2018-2023)
-
Table Farmhispania Company Profile
-
Table Farmhispania Aprepitant Revenue, Price and Gross (2018-2023)
-
Table Royesh Daru Pars Co Company Profile
-
Table Royesh Daru Pars Co Aprepitant Revenue, Price and Gross (2018-2023)
-
Table Zhongshan Follow Biotech Company Profile
-
Table Zhongshan Follow Biotech Aprepitant Revenue, Price and Gross (2018-2023)
-
Table Cayman Company Profile
-
Table Cayman Aprepitant Revenue, Price and Gross (2018-2023)
-
Table Mehta Company Profile
-
Table Mehta Aprepitant Revenue, Price and Gross (2018-2023)
-
Table Wuhai Yuancheng Technology Co,Ltd Company Profile
-
Table Wuhai Yuancheng Technology Co,Ltd Aprepitant Revenue, Price and Gross (2018-2023)
-
Table Hetero Company Profile
-
Table Hetero Aprepitant Revenue, Price and Gross (2018-2023)
-
Table Beijing Langfang Gaobo Jingbang Pharmaceutical Company Profile
-
Table Beijing Langfang Gaobo Jingbang Pharmaceutical Aprepitant Revenue, Price and Gross (2018-2023)
-
Table Jubilant Pharma Company Profile
-
Table Jubilant Pharma Aprepitant Revenue, Price and Gross (2018-2023)
-
Table Bondbay Pharma Company Profile
-
Table Bondbay Pharma Aprepitant Revenue, Price and Gross (2018-2023)
-
Table Zhongshan Enantiotech Corporation Company Profile
-
Table Zhongshan Enantiotech Corporation Aprepitant Revenue, Price and Gross (2018-2023)
-
Table Nanjing Gold Pharmaceutical Technology Co,Ltd Company Profile
-
Table Nanjing Gold Pharmaceutical Technology Co,Ltd Aprepitant Revenue, Price and Gross (2018-2023)
-
Table Wujiang Xiehe Pharmaceutical Co,Ltd Company Profile
-
Table Wujiang Xiehe Pharmaceutical Co,Ltd Aprepitant Revenue, Price and Gross (2018-2023)
-
Table Chengdu Henghui Pharmaceutical Company Profile
-
Table Chengdu Henghui Pharmaceutical Aprepitant Revenue, Price and Gross (2018-2023)
-
